Previous 10 | Next 10 |
2023-05-09 19:56:03 ET Exact Sciences Corporation (EXAS) Q1 2023 Earnings Conference Call May 9, 2023 05:00 PM ET Company Participants Megan Jones - IR Kevin Conroy - Chairman & CEO Jeffrey Elliott - CFO & COO Everett Cunningham - Chief Commercial Off...
2023-05-09 16:12:31 ET Exact Sciences press release ( NASDAQ: EXAS ): Q1 GAAP EPS of -$0.42 beats by $0.34 . Revenue of $602.45M (+23.8% Y/Y) beats by $59.27M . Expect to turn free cash flow positive during 2023, ahead of previous target of 2024 Core revenu...
Exact Sciences Announces First Quarter 2023 Results PR Newswire Reports record results, raises full-year guidance, accelerates path to positive free cash flow First quarter highlights Total first quarter revenue of $602 million , an increase of 24%, and $...
Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting PR Newswire Results of three modeling studies demonstrated that non-invasive colorectal cancer screening with Cologuard ® is more ef...
2023-05-04 16:20:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2023, Baron Health Care Fund declined 3.69%, compared w...
2023-05-02 03:11:45 ET Summary Fortune is slowly turning in favor of Cathie Wood and her investment management firm as the rapid decline of her ETFs and their underlying assets has perhaps finally bottomed. Front-running tech stocks have delivered unexpectedly good earnings in def...
2023-04-29 04:20:36 ET Summary Demographic trends are powerful and experience little impact from economic cycles. As the Millennial generation enters middle age and surpasses the number of Baby Boomers, the demand for medical screening and testing will increase. Exact Sciences...
2023-04-25 06:35:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body. It promises to revolutio...
2023-04-20 19:57:09 ET Summary Shares of liquid biopsy genetic profiling test developer Guardant Health, Inc. have cratered 85% since achieving their all-time high of $181.07 in February 2021. Slowing top line growth, a very long timeline to profitability that includes a significa...
2023-04-15 05:39:00 ET Cathie Wood's flagship exchange-traded fund, the ARK Innovation ETF, is trouncing the S&P 500 this year with a 20.5% gain versus just 6.6% for the benchmark index. Despite a big run-up to start 2023, Cathie Wood and Ark Invest think some of their favor...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...